FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2107707938> ?p ?o ?g. }

• W2107707938 endingPage "4148" @default.
• W2107707938 startingPage "4137" @default.
• W2107707938 abstract "Abstract Purpose: Individual or combined strategies of cellular therapy with alloreactive CTLs (alloCTL) and gene therapy using retroviral replicating vectors (RRV) encoding a suicide prodrug activating gene were explored for the treatment of breast tumors metastatic to the brain. Experimental Design: AlloCTL, sensitized to the HLA of MDA-MB-231 breast cancer cells, were examined in vitro for antitumor functionality toward breast cancer targets. RRV encoding the yeast cytosine deaminase (CD) gene was tested in vivo for virus spread, ability to infect, and kill breast cancer targets when exposed to 5-fluorocytosine (5-FC). Individual and combination treatments were tested in subcutaneous and intracranial xenograft models with 231BR, a brain tropic variant. Results: AlloCTL preparations were cytotoxic, proliferated, and produced IFN-γ when coincubated with target cells displaying relevant HLA. In vivo, intratumorally placed alloCTL trafficked through one established intracranial 231BR focus to another in contralateral brain and induced tumor cell apoptosis. RRV-CD efficiently spread in vivo, infected 231BR and induced their apoptosis upon 5-FC exposure. Subcutaneous tumor volumes were significantly reduced in alloCTL and/or gene therapy–treated groups compared to control groups. Mice with established intracranial 231BR tumors treated with combined alloCTL and RRV-CD had a median survival of 97.5 days compared with single modalities (50–83 days); all experimental treatment groups survived significantly longer than sham-treated groups (median survivals 31.5 or 40 days) and exhibited good safety/toxicity profiles. Conclusion: The results indicate combining cellular and suicide gene therapies is a viable strategy for the treatment of established breast tumors in the brain. Clin Cancer Res; 19(15); 4137–48. ©2013 AACR." @default.
• W2107707938 created "2016-06-24" @default.
• W2107707938 creator A5003100815 @default.
• W2107707938 creator A5015193605 @default.
• W2107707938 creator A5025832921 @default.
• W2107707938 creator A5031668722 @default.
• W2107707938 creator A5043863125 @default.
• W2107707938 creator A5044188173 @default.
• W2107707938 creator A5057243738 @default.
• W2107707938 creator A5063562007 @default.
• W2107707938 creator A5079188247 @default.
• W2107707938 creator A5082324887 @default.
• W2107707938 creator A5083605239 @default.
• W2107707938 creator A5088095294 @default.
• W2107707938 creator A5089363970 @default.
• W2107707938 date "2013-07-31" @default.
• W2107707938 modified "2023-09-23" @default.
• W2107707938 title "Combined Alloreactive CTL Cellular Therapy with Prodrug Activator Gene Therapy in a Model of Breast Cancer Metastatic to the Brain" @default.
• W2107707938 cites W1492579672 @default.
• W2107707938 cites W1496592197 @default.
• W2107707938 cites W1630218117 @default.
• W2107707938 cites W1851819680 @default.
• W2107707938 cites W1972511495 @default.
• W2107707938 cites W1974473991 @default.
• W2107707938 cites W1980457576 @default.
• W2107707938 cites W1991685243 @default.
• W2107707938 cites W1995192046 @default.
• W2107707938 cites W2002066502 @default.
• W2107707938 cites W2010055753 @default.
• W2107707938 cites W2011913930 @default.
• W2107707938 cites W2026987067 @default.
• W2107707938 cites W2035414562 @default.
• W2107707938 cites W2037383080 @default.
• W2107707938 cites W2039978626 @default.
• W2107707938 cites W2040921647 @default.
• W2107707938 cites W2054392959 @default.
• W2107707938 cites W2070201923 @default.
• W2107707938 cites W2075816261 @default.
• W2107707938 cites W2078675119 @default.
• W2107707938 cites W2082833890 @default.
• W2107707938 cites W2083120527 @default.
• W2107707938 cites W2089042535 @default.
• W2107707938 cites W2091356936 @default.
• W2107707938 cites W2097601869 @default.
• W2107707938 cites W2134912068 @default.
• W2107707938 cites W2139085578 @default.
• W2107707938 cites W2155127143 @default.
• W2107707938 cites W2162065895 @default.
• W2107707938 cites W2170997877 @default.
• W2107707938 doi "https://doi.org/10.1158/1078-0432.ccr-12-3735" @default.
• W2107707938 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3939036" @default.
• W2107707938 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23780889" @default.
• W2107707938 hasPublicationYear "2013" @default.
• W2107707938 type Work @default.
• W2107707938 sameAs 2107707938 @default.
• W2107707938 citedByCount "5" @default.
• W2107707938 countsByYear W21077079382013 @default.
• W2107707938 countsByYear W21077079382018 @default.
• W2107707938 countsByYear W21077079382020 @default.
• W2107707938 countsByYear W21077079382022 @default.
• W2107707938 crossrefType "journal-article" @default.
• W2107707938 hasAuthorship W2107707938A5003100815 @default.
• W2107707938 hasAuthorship W2107707938A5015193605 @default.
• W2107707938 hasAuthorship W2107707938A5025832921 @default.
• W2107707938 hasAuthorship W2107707938A5031668722 @default.
• W2107707938 hasAuthorship W2107707938A5043863125 @default.
• W2107707938 hasAuthorship W2107707938A5044188173 @default.
• W2107707938 hasAuthorship W2107707938A5057243738 @default.
• W2107707938 hasAuthorship W2107707938A5063562007 @default.
• W2107707938 hasAuthorship W2107707938A5079188247 @default.
• W2107707938 hasAuthorship W2107707938A5082324887 @default.
• W2107707938 hasAuthorship W2107707938A5083605239 @default.
• W2107707938 hasAuthorship W2107707938A5088095294 @default.
• W2107707938 hasAuthorship W2107707938A5089363970 @default.
• W2107707938 hasBestOaLocation W21077079381 @default.
• W2107707938 hasConcept C104317684 @default.
• W2107707938 hasConcept C108215921 @default.
• W2107707938 hasConcept C111599444 @default.
• W2107707938 hasConcept C121608353 @default.
• W2107707938 hasConcept C126322002 @default.
• W2107707938 hasConcept C150903083 @default.
• W2107707938 hasConcept C154317977 @default.
• W2107707938 hasConcept C19106626 @default.
• W2107707938 hasConcept C202751555 @default.
• W2107707938 hasConcept C203014093 @default.
• W2107707938 hasConcept C207001950 @default.
• W2107707938 hasConcept C2777748644 @default.
• W2107707938 hasConcept C34981463 @default.
• W2107707938 hasConcept C502942594 @default.
• W2107707938 hasConcept C530470458 @default.
• W2107707938 hasConcept C55493867 @default.
• W2107707938 hasConcept C71924100 @default.
• W2107707938 hasConcept C86803240 @default.
• W2107707938 hasConcept C98274493 @default.
• W2107707938 hasConceptScore W2107707938C104317684 @default.
• W2107707938 hasConceptScore W2107707938C108215921 @default.
• W2107707938 hasConceptScore W2107707938C111599444 @default.
• W2107707938 hasConceptScore W2107707938C121608353 @default.

• next